TF and central nervous system cancer: In the case of high-grade gliomas, JAK1/2-STAT3 along with a hypoxia-induced pathway utilizing hypoxia-inducible factor 1α (HIF-1α) TF has been reported for enhancing the self-renewal capability of glioma stem-like cells (178, 181, 185).